Alicorn Pharmaceutical

Alicorn Pharmaceutical Co., Ltd. is a research-driven biotechnology company headquartered in Haining, China, specializing in the development and manufacturing of small molecule therapeutics. Founded in 2015, the company focuses on high-impact therapeutic areas including oncology, autoimmune diseases, cardiovascular conditions, and central nervous system disorders. Alicorn operates an integrated business model that spans from AI-powered drug discovery and process optimization to large-scale GMP manufacturing of APIs and finished dosage forms. The company maintains state-of-the-art R&D centers in Nanjing and Jiaxing, alongside a comprehensive production base in Anqing. Through its specialized technology platforms, Alicorn develops a diverse portfolio of innovative, modified, and generic drugs while also providing CRO and CDMO services to global partners.